Toimialayhteisöt

 

This document applies to the design, energy performance of buildings and implementation of ventilation, air conditioning and room conditioning systems for non-residential buildings subject to human occupancy, excluding applications like industrial processes. It focuses on the definitions of the various parameters that are relevant for such systems. The guidance for design given in this document and accompanying CEN/TR 16798-4 are mainly applicable to mechanical supply and/or exhaust ventilation systems. Natural ventilation systems or natural parts of hybrid ventilation systems are not covered by this document. Applications for residential ventilation are not covered in this document. Performance of ventilation systems in residential buildings is covered in EN 15665 and CEN/TR 14788. The classification uses different categories. For some values, examples are given and, for requirements, typical ranges with default values are presented. The default values are given in Annex B and a template for national specification is given in Annex A. It is important that the classification is always appropriate to the type of building and its intended use, and that the basis of the classification is explained if the examples given in this document are not used. NOTE 1 Different standards can express the categories for the same parameters in a different way, and also the category symbols can be different. Table 1 shows the relative position of this document within the set of EPB standards in the context of the modular structure as set out in EN ISO 52000-1. NOTE 2 In CEN ISO/TR 52000-2 the same Table can be found, with, for each module, the numbers of the relevant EPB standards and accompanying technical reports that are published or in preparation. NOTE 3 The modules represent EPB standards, although one EPB standard might cover more than one module and one module might be covered by more than one EPB standard, for instance a simplified and a detailed method respectively. See also Clause 2 and Table A.1 and Table B.1. Table 1 - Position of this standard (in case M5-1, M5-4), within the modular structure of the set of EPB standards

 

This document specifies the conditions for the determination of uniaxial tensile properties of ceramic matrix composite (CMC) tubes with continuous fibre-reinforcement at elevated temperature in air, vacuum and inert gas atmospheres. This document is specific to the tubular geometries because fibre architecture and specimen geometry factors in composite tubes are distinctly different from those in flat specimens. This document provides information on the axial tensile properties and stress-strain response in temperature, such as axial tensile strength, axial tensile strain at failure and elastic constants. The information can be used for material development, control of manufacturing (quality insurance), material comparison, characterization, reliability and design data generation for tubular components. This document addresses, but is not restricted to, various suggested test piece fabrication methods. It applies primarily to ceramic matrix composite tubes with a continuous fibrous-reinforcement: unidirectional (1D, filament winding and tape lay-up), bi-directional (2D, braid and weave) and multi-directional (xD, with x > 2), tested along the tube axis.

 

 

This International Standard specifies ways in which rare earths can be traced as they move through the supply chain between the separated products to rare earth permanent magnets, or otherwise further processed. This standard complements ISO 23664. The documented traceability information will assist purchasers, suppliers, and users of rare earth permanent magnets to identify parties in the supply chain who have processed a given shipment of rare earth material, the location of that rare earth material as it passes between supply chain nodes. Supply chain actors and end users can use this information to check the validity of any claims made on the rare earth permanent magnets concerning sustainability, environmental impact, or recycled material content.

 

 

This document defines a method of determining bulk density of solid recovered fuels by the use of a standard measuring container. This method is applicable to all SRFs with a nominal top size of particle less than 1/3 of the container diameter specified in this document.

 

This document specifies methods for measuring and evaluating the performance of CO2 capture connected to a CO2 intensive plant, and which separate CO2 from the CO2 intensive plant exhaust gas in preparation for subsequent transportation and geological storage. In particular, it provides a common methodology to calculate key performance indicators for the CO2 capture plant, requiring the definition of the boundaries of a typical system and the measurements of parameters needed to determine the KPIs. This document covers the CO2 capture plant capturing CO2 from CO2 containing exhaust gas” connected to CO2 intensive plants. The connection of a CO2-capture plant to a CO2-intensive plant is anticipated to have negligible impact on the product quality or the quantities produced by the CO2-intensive plant. This is in contrast with the integration of CO2-capture plants with power plants which usually results in a reduction of the power plant output. For the CO2-intensive industry it is important that product quality remains the same after connection of the CO2-capture plant, in order for the industry to continue to meet customer requirements. The CO2 capture technologies covered by this document are able to operate without interfering with the operations of the CO2 intensive plant. Frequently used CO2 capture technologies are chemical absorption (e.g., liquid amine) and solid adsorption (e.g., Pressure Swing Adsorption (PSA), Temperature Swing Adsorption (TSA)). Other CO2 capture concepts are membranes, cryogenic and other capture technologies. The CO2 capture plant can be installed for treatment of the full volume of exhaust gas from the CO2 intensive plant or a fraction of the total (i.e. a slipstream). Captured CO2 is then conditioned, e.g. dried and compressed or liquefied, as determined by the conditions needed for transportation and storage. The transportation can be either through a pipeline or through an intermediate storage facility waiting for shipment; either by tanker car, train, or ship. The KPIs considered in this document are the following: The calculations are based on measurements at the boundary of the CO2 capture plant, particularly of energy and other utilities consumption. The system includes interfaces between the CO2 capture plant and the CO2 intensive plant. This document includes the following items: This document does not provide guidelines for benchmarking, comparing, or assessing KPIs of different technologies or different CO2 capture projects.

 

 

 

This document specifies common requirements for transportable liquid oxygen systems and specific requirements for base units. Base units are used as a store for liquid oxygen for recharging portable units. They may also, if fitted with a flow outlet and flow selector, be used as a source for the supply of oxygen direct to the patient.

 

This document specifies requirements for portable units which are part of a transportable liquid oxygen system. These are used as a supply source for oxygen therapy in home-care and in health-care facilities. Portable units are intended to be carried by patients whilst moving around and during their off-site activities and can be refilled from a base unit through a transfilling connector. Portable units are used without professional supervision.

 

This part of ISO/IEC 19770 provides This part of ISO/IEC 19770 is applicable to all types of organizations (e.g., commercial enterprises, government agencies, and non-profit organizations).

 

Tiedoksi lausunnonantajalle:

Lausunnon ensisijaisena tarkoituksena on vastaanottaa kommentteja ja kannanottoja suomalaisilta yksityishenkilöiltä ja organisaatioilta standardiluonnoksen teknistä sisältöä ja hyväksymistä koskien. Vastaa kohdassa ’Ota kantaa’ tulisiko tämä standardiluonnos hyväksyä maailmanlaajuiseksi ISO-standardiksi. Kantasi ja kommenttisi otetaan huomioon Suomen kannan muodostamisessa lausunnon eräännyttyä.

Yllä olevan lisäksi keräämme tällä lausunnolla kannanottoja standardiluonnoksen vahvistamiseksi kansalliseksi SFS-ISO-standardiksi. Jätä kommenttisi tätä koskien kohdassa ’Lue ehdotus’ — tulisiko tämä ISO-standardiluonnos vahvistaa kansalliseksi SFS-ISO-standardiksi*.

*SFS:n tehtävänä on ylläpitää suomalaista SFS-standardikokoelmaa. Maailmanlaajuisten standardien kohdalla ISO vahvistaa standardin ensin, ja Suomi päättää sen jälkeen, vahvistaako se standardin vai ei. Vahvistamispäätökseen vaikuttaa alan suomalainen näkemys ja kiinnostus vahvistettavaan standardiin.

 

This document specifies requirements and provides recommendations for the pre-examination phase of cell free DNA (cfDNA) from body fluid specimens other than blood, including but not limited to the collection, handling, storage, transport, processing and documentation of human body fluids, such as urine, pleural effusions, ascites, cerebrospinal fluid (CSF), and saliva, intended for cfDNA examination. Processing includes multiple steps, such as centrifugation for specimen purification and isolation of cfDNA. This document is applicable to medical laboratories, health institutions including facilities collecting and handling specimens, laboratory customers, in vitro diagnostic examination developers and manufacturers, biobanks, institutions and organizations performing biomedical research, and regulatory authorities. Dedicated measures that need to be taken for cytohistological analysis of body fluid derived nucleated cells are not described in this document, neither are measures for preserving and handling of pathogens, and other bacterial or whole microbiome DNA in body fluids described. Different dedicated measures need to be taken for preserving circulating cell free DNA (ccfDNA) from blood. These are not described in this document, but are covered in ISO 20186-3.

 

This document is a product specification, giving performance requirements for emergency safety body showers connected to the water supply. It is applicable to plumbed-in body showers only, located in laboratory facilities. Requirements are given in respect of the performance, installation, adjustment and marking of the showers as well as installation, operation and maintenance instructions to be given by the manufacturer. NOTE Attention is drawn to national regulations which might apply in respect of the installation and use of emergency safety showers.

 

This document is a product specification, giving performance requirements for emergency safety eye-wash units connected to the water supply. It is applicable to plumbed-in eye-wash units only. Requirements are given in respect of the performance, installation, adjustment and marking of the eye-wash units, as well as installation, operation and maintenance instructions to be given by the manufacturer. NOTE Attention is drawn to national regulations which can apply in respect of the installation and use of eye-wash units.

 

 

This document contains simulation software for the MPEG-H 3D audio standard as defined in ISO/IEC 23008-3.

 

ISO 11431:2002 specifies a method for the determination of the adhesion/cohesion properties of sealants after cyclic exposure to heat and artificial light followed by a period of exposure to water at a defined temperature.

 

This international standard defines a method of determining bulk density of solid recovered fuels by the use of a standard measuring container.

 

This document specifies requirements and provides recommendations for the pre-examination phase of cell free DNA (cfDNA) from body fluid specimens other than blood, including but not limited to the collection, handling, storage, transport, processing and documentation of human body fluids, such as urine, cerebrospinal fluid (CSF), pleural effusions and saliva, intended for cfDNA examination. Processing includes multiple steps, such as centrifugation for specimen cleaning and isolation of cfDNA. This document is applicable to molecular in vitro diagnostic examinations performed by medical laboratories. It is also intended to be used by health institutions including facilities collecting and handling specimen, laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. Dedicated measures that need to be taken for cytohistological analysis of body fluid derived nucleated cells are not described in this document. Neither are measures for preserving and handling of pathogens, and other bacterial or whole microbiome DNA in body fluids described. Different dedicated measures need to be taken for preserving circulating cell free DNA (ccfDNA) from blood. These are not described in this document, but are covered in ISO 20186-3. NOTE International, national or regional regulations or requirements can also apply to specific topics covered in this document.